Summit Therapeutics Inc. Income Statement

Income Statement Jan2013 Jan2014 Jan2015 Jan2016 Jan2017 Jan2018 Jan2019 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 3.01M-0.02M-0.81M-4.38M0.00M-3.79M57.09M0.74M0.86M1.81M0.70M-15.46M-8.69M
Gross Profit 3.01M-0.02M-0.81M-4.38M0.00M-3.79M57.09M0.74M0.86M1.81M0.70M-15.46M-8.69M
Operating items
Research & Development -7.52M-0.01M-0.02M-0.03M-0.03M52.00M39.81M53.27M85.35M52.00M59.47M150.78M
Selling, General & Administrative -2.77M-0.00M-0.01M-0.01M-0.01M17.01M11.28M19.23M23.61M26.74M30.27M60.53M
Other Operating Expenses 0.00M0.06M0.06M0.01M0.86M14.42M1.00M0.31M
Operating Expenses -10.28M-0.01M-0.02M-0.03M-0.04M74.31M51.09M73.36M108.96M87.21M610.65M226.31M
Operating Income -7.27M-0.01M-0.02M-0.03M-0.03M5.39M-27.47M-53.19M-86.19M-72.09M-609.65M-226.00M
EBIT -7.27M-0.01M-0.02M-0.03M-0.03M-13.80M5.39M-27.47M-53.19M-86.19M-72.09M-609.65M-226.00M
Non-operating items
Interest & Investment Income 0.02M0.00M-0.08M-0.04M-0.01M-4.39M-3.66M0.01M
Other Non Operating Income 0.01M0.03M0.12M-0.24M0.89M2.78M-0.54M0.72M
Non Operating Income 3.69M-1.62M0.28M-2.42M-2.29M11.18M13.37M
Net income details
EBT -7.26M-0.01M-19.02M-28.57M-32.35M-15.46M9.08M-29.09M-52.91M-88.60M-78.78M-614.93M-234.68M
Tax Provisions -1.79M0.04M-0.21M
Profit After Tax -7.26M-0.01M-19.02M-28.57M-32.35M-26.26M10.87M-29.13M-52.70M-88.60M-78.78M-614.93M-221.31M
Income from Continuing Operations -7.26M-0.01M-19.02M-28.57M-32.35M-15.46M10.87M-29.13M-52.70M-88.60M-78.78M-614.93M-234.68M
Consolidated Net Income -7.26M-0.01M-19.02M-28.57M-32.35M-15.46M10.87M-29.13M-52.70M-88.60M-78.78M-614.93M-234.68M
Income towards Parent Company -7.26M-0.01M-19.02M-28.57M-32.35M-15.46M10.87M-29.13M-52.70M-88.60M-78.78M-614.93M-234.68M
Net Income towards Common Stockholders -7.26M-0.01M-19.02M-28.57M-32.35M-15.46M10.87M-29.13M-52.70M-88.60M-78.78M-614.93M-234.68M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 11.67M11.67M11.67M12.26M12.37M32.08M32.08M82.26M97.71M201.32M700.84M737.45M
Shares Outstanding (Diluted Average) 22.88M41.92M69.52M131.71M193.34M619.65M718.54M
EBITDA -7.27M-0.01M-0.02M-0.03M-0.03M-13.80M10.37M-29.08M-51.73M-87.00M-78.48M-615.48M-221.15M
Tax Rate 0.40%